产品标题 产品货号 产品规格 厂家
CTLA4 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2101501 kitORIGENE TECHNOLOGIES
CTNNA3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2132651 kitORIGENE TECHNOLOGIES
CTNNA3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN213265LP1 kitORIGENE TECHNOLOGIES
CTNNA3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN213265BN1 kitORIGENE TECHNOLOGIES
CTNNA3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN213265RB1 kitORIGENE TECHNOLOGIES
CTNNA1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4017661 kitORIGENE TECHNOLOGIES
CTNNA2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4087311 kitORIGENE TECHNOLOGIES
CTNNA3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4132651 kitORIGENE TECHNOLOGIES
Human Adrenal gland; Pheochromocytoma from ORIGENE TECHNOLOGIESCS6447375x5umORIGENE TECHNOLOGIES
Human Adrenal gland; Pheochromocytoma, metastatic from ORIGENE TECHNOLOGIESCS7169235x5umORIGENE TECHNOLOGIES
Human Adrenal gland; Pheochromocytoma, metastatic from ORIGENE TECHNOLOGIESCS7169245x5umORIGENE TECHNOLOGIES
Human Adrenal gland; Tumor of adrenal gland, neuroendocrine, composite from ORIGENE TECHNOLOGIESCS7015125x5umORIGENE TECHNOLOGIES
Human Adrenal gland; Tumor of adrenal gland, neuroendocrine, composite from ORIGENE TECHNOLOGIESCS7015135x5umORIGENE TECHNOLOGIES
Human Adrenal gland; Tumor of adrenal gland, neuroendocrine, composite from ORIGENE TECHNOLOGIESCS5052615x5umORIGENE TECHNOLOGIES
Human adrenergic, beta, receptor kinase 1 (ADRBK1) from ORIGENE TECHNOLOGIESTP31032720 ugORIGENE TECHNOLOGIES
Human adrenocortical dysplasia homolog (mouse) (ACD), transcript variant 1 from ORIGENE TECHNOLOGIESTP30438120 ugORIGENE TECHNOLOGIES
NPS - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4113611 kitORIGENE TECHNOLOGIES
Nps - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5111751 kitORIGENE TECHNOLOGIES
NPSR1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN220736BN1 kitORIGENE TECHNOLOGIES
NPSR1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2207361 kitORIGENE TECHNOLOGIES
NPSR1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN220736LP1 kitORIGENE TECHNOLOGIES
NPSR1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN220736RB1 kitORIGENE TECHNOLOGIES
NPSR1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4207361 kitORIGENE TECHNOLOGIES
Npsr1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5111761 kitORIGENE TECHNOLOGIES
Human NDC80 homolog, kinetochore complex component (S. cerevisiae) (NDC80) from ORIGENE TECHNOLOGIESTP30756520 ugORIGENE TECHNOLOGIES
Human N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (NDST1) from ORIGENE TECHNOLOGIESTP32163820 ugORIGENE TECHNOLOGIES
Human N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 (NDST3) from ORIGENE TECHNOLOGIESTP31755120 ugORIGENE TECHNOLOGIES
Rp2h - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5149921 kitORIGENE TECHNOLOGIES
RPIA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4021831 kitORIGENE TECHNOLOGIES
Rpia - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5150101 kitORIGENE TECHNOLOGIES
RPIA Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30218310 ugORIGENE TECHNOLOGIES
Elastin microfibril interfacer 2 (EMILIN2) from ORIGENE TECHNOLOGIESLY410362100 ugORIGENE TECHNOLOGIES
Elastin microfibril interfacer 3 (EMILIN3) from ORIGENE TECHNOLOGIESLY409456100 ugORIGENE TECHNOLOGIES
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) (ELAVL2), transcript variant 2 from ORIGENE TECHNOLOGIESLY432918100 ugORIGENE TECHNOLOGIES
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) (ELAVL3), transcript variant 1 from ORIGENE TECHNOLOGIESLY419944100 ugORIGENE TECHNOLOGIES
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) (ELAVL3), transcript variant 2 from ORIGENE TECHNOLOGIESLY410225100 ugORIGENE TECHNOLOGIES
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) (ELAVL3), transcript variant 2 from ORIGENE TECHNOLOGIESLY429801100 ugORIGENE TECHNOLOGIES
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) (ELAVL4), transcript variant 1 from ORIGENE TECHNOLOGIESLY411863100 ugORIGENE TECHNOLOGIES
Human variable charge, X-linked 3A (VCX3A) from ORIGENE TECHNOLOGIESTP32100220 ugORIGENE TECHNOLOGIES
Human variable charge, X-linked (VCX) from ORIGENE TECHNOLOGIESTP32449720 ugORIGENE TECHNOLOGIES
Human variable charge, X-linked 2 (VCX2) from ORIGENE TECHNOLOGIESTP31399720 ugORIGENE TECHNOLOGIES
Human Varicella-Zoster-Virus (VZV) IgG ELISA kit from ORIGENE TECHNOLOGIESEA1009678x12 divisible stripsORIGENE TECHNOLOGIES
Human Varicella-Zoster-Virus (VZV) IgM ELISA kit from ORIGENE TECHNOLOGIESEA1009688x12 divisible stripsORIGENE TECHNOLOGIES
Human vascular cell adhesion molecule 1 (VCAM1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30976120 ugORIGENE TECHNOLOGIES
Human vascular cell adhesion molecule 1 (VCAM1), transcript variant 2 from ORIGENE TECHNOLOGIESTP31335320 ugORIGENE TECHNOLOGIES
Human vascular cell adhesion molecule 1 (VCAM1), transcript variant 1 from ORIGENE TECHNOLOGIESTP72062710 ugORIGENE TECHNOLOGIES
Human vascular cell adhesion molecule 1 (VCAM1), transcript variant 1. from ORIGENE TECHNOLOGIESTP72346850 ugORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049555x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049565x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049585x5umORIGENE TECHNOLOGIES
 |< < 5356 5357 5358 5359 5360 5361 5362 5363 5364 > >| 第 5358/6274 页